The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding
Open accessAbstract
The adverse effects of angiotensin II (Ang II) are primarily mediated through the Ang II type 1 receptor (AT1R). A silent polymorphism (+1166 A/C) in the human AT1R gene has been associated with cardiovascular disease, possibly as a result of enhanced AT(1)R activity. Because this polymorphism occurs in the 3'-untranslated region of the human AT1R gene, the biological importance of this mutation has always been questionable. Computer alignment demonstrated that the +1166 A/C polymorphism occurred in a cis-regulatory site, which is recognized by a specific microRNA (miRNA), miR-155. miRNAs are noncoding RNAs that silence gene expression by base-pairing with complementary sequences in the 3'-untranslated region of target RNAs. When the +1166 C-allele is present, base-pairing complementarity is interrupted, and the ability of miR-155 to interact with the cis-regulatory site is decreased. As a result, miR-155 no longer attenuates translation as efficiently as demonstrated by luciferase reporter and Ang II radioreceptor binding assays. In situ hybridization experiments demonstrated that mature miR-155 is abundantly expressed in the same cell types as the AT1R (e.g. endothelial and vascular smooth muscle). Finally, when human primary vascular smooth muscle cells were transfected with an antisense miR-155 inhibitor, endogenous human AT1R expression and Ang II-induced ERK1/2 activation were significantly increased. Taken together, our study demonstrates that the AT1R and miR-155 are co-expressed and that miR-155 translationally represses the expression of AT1R in vivo. Therefore, our study provides the first feasible biochemical mechanism by which the +1166 A/C polymorphism can lead to increased AT1R densities and possibly cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
MicroRNA-155 Regulates Human Angiotensin II Type 1 Receptor Expression in Fibroblasts
Martin, M. M., Lee, E. J., Buckenberger, J. A., Schmittgen, T. D., & Elton, T. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601496200 · Cited by 225
Self-citationRetractedRETRACTED: TGF-β1 regulation of human AT1 receptor mRNA splice variants harboring exon 2
Martin, M. M., Buckenberger, J. A., Knoell, D. L., Strauch, A. R., & Elton, T. S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.01.009 · Cited by 8
Self-citationRetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Non-coding RNAs and cancer: microRNAs and beyond
Raia, R. M., & Calin, G. A. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e5 · Cited by 3,382
RNA interference is mediated by 21- and 22-nucleotide RNAs
Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310
Fast and effective prediction of microRNA/target duplexes
REHMSMEIER, M., STEFFEN, P., HÖCHSMANN, M., & GIEGERICH, R. (2004) · RNA · doi:10.1261/rna.5248604 · Cited by 2,560
Principles of MicroRNA–Target Recognition
Brennecke, J., Stark, A., Russell, R. B., & Cohen, S. M. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030085 · Cited by 2,378
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Specificity of microRNA target selection in translational repression
Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636
Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibé, B., Bouix, J., Caiment, F., Elsen, J.-M., Eychenne, F., et al. (2006) · Nature Genetics · doi:10.1038/ng1810 · Cited by 1,260
Doench, J. G., Petersen, C. P., & Sharp, P. A. (2003) · Genes & Development · doi:10.1101/gad.1064703 · Cited by 1,260
Olsen, P. H., & Ambros, V. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9523 · Cited by 1,234
The role of microRNA genes in papillary thyroid carcinoma
He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C.-G., Franssila, K., Suster, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,215
Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940
Zeng, Y., Wagner, E. J., & Cullen, B. R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00541-5 · Cited by 831
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.
Bonnardeaux, A., Davies, E., Jeunemaitre, X., Féry, I., Charru, A., Clauser, E., Tiret, L., Cambien, F., Corvol, P., & Soubrier, F. (1994) · Hypertension · doi:10.1161/01.hyp.24.1.63 · Cited by 726
Vitale, A. V., Tan, H., & Jin, P. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.2236 · Cited by 623
Sequence-specific inhibition of small RNA function
Hutvágner, G., Simard, M. J., Mello, C. C., & Zamore, P. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020098 · Cited by 584
Real-time expression profiling of microRNA precursors in human cancer cell lines
Jiang, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki863 · Cited by 501
Self-citationNatural selection on human microRNA binding sites inferred from SNP data
Chen, K., & Rajewsky, N. (2006) · Nature Genetics · doi:10.1038/ng1910 · Cited by 469
Tiret, L., Ducimetière, P., Bonnardeaux, A., Soubrier, F., Poirier, O., Ricard, S., Cambien, F., Marques-Vidal, P., Evans, A., Kee, F., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92268-3 · Cited by 416
Seggerson, K., Tang, L., & Moss, E. G. (2002) · Developmental Biology · doi:10.1006/dbio.2001.0563 · Cited by 403
Benetos, A., Gautier, S., Ricard, S., Topouchian, J., Asmar, R., Poirier, O., Larosa, E., Guize, L., Safar, M., Soubrier, F., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.698 · Cited by 271
Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis
Altmann, M., & Hammerschmidt, W. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030404 · Cited by 266
Genotype-Phenotype Relationships for the Renin-Angiotensin-Aldosterone System in a Normal Population
Paillard, F., Chansel, D., Brand, E., Benetos, A., Thomas, F., Czekalski, S., Ardaillou, R., & Soubrier, F. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.423 · Cited by 206
Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension
Wang, W. Y. S., Zee, R. L., & Morris, B. J. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02410.x · Cited by 167
van Geel, P. P., Pinto, Y. M., Voors, A. A., Buikema, H., Oosterga, M., Crijns, H. J. G. M., & van Gilst, W. H. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.717 · Cited by 167
The role of angiotensin II in regulating vascular structural and functional changes in hypertension
Touyz, R. M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0073-2 · Cited by 145
Osterop, A. P. R. M., Kofflard, M. J. M., Sandkuijl, L. A., ten Cate, F. J., Krams, R., Schalekamp, M. A. D. H., & Danser, A. H. J. (1998) · Hypertension · doi:10.1161/01.hyp.32.5.825 · Cited by 123
Amant, C., Hamon, M., Bauters, C., Richard, F., Helbecque, N., McFadden, E. P., Escudero, X., Lablanche, J., Amouyel, P., & Bertrand, M. E. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00535-9 · Cited by 118
Intron-derived microRNAs—fine tuning of gene functions
Ying, S., & Lin, S.-L. (2004) · Gene · doi:10.1016/j.gene.2004.07.025 · Cited by 110
Regulation of α2-adrenoceptors in human vascular smooth muscle cells
Chotani, M. A., Mitra, S., Su, B. Y., Flavahan, S., Eid, A. H., Clark, K. R., Montague, C. R., Paris, H., Handy, D. E., & Flavahan, N. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00268.2003 · Cited by 107
Self-citationSpiering, W., Kroon, A. A., Fuss-Lejeune, M. J. M. J., Daemen, M. J. A. P., & de Leeuw, P. W. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.411 · Cited by 93
A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution
Lin, S.-L., Chang, D., Wu, D.-Y., & Ying, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.070 · Cited by 89
Angiotensin II-mediated signal transduction pathways
Saito, Y., & Berk, B. C. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0042-1 · Cited by 67
The MicroRNA: Overview of the RNA Gene That Modulates Gene Functions
Ying, S., Chang, D. C., Miller, J. D., & Lin, S.-L. (2006) · Humana Press eBooks · doi:10.1385/1-59745-123-1:1 · Cited by 62
Cameron, V. A., Mocatta, T. J., Pilbrow, A. P., Frampton, C. M., Troughton, R. W., Richards, M., & Winterbourn, C. C. (2006) · Hypertension · doi:10.1161/01.hyp.0000222893.85662.cd · Cited by 54
Destabilization of AT 1 Receptor mRNA by Calreticulin
Nickenig, G., Michaelsen, F., Müller, C., Berger, A., Vogel, T., Sachinidis, A., Vetter, H., & Böhm, M. (2002) · Circulation Research · doi:10.1161/hh0102.102503 · Cited by 48
Martin, M. M., Willardson, B. M., Burton, G. F., White, C. R., McLaughlin, J. N., Bray, S. M., Ogilvie, J. W., & Elton, T. S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.2.0598 · Cited by 42
Self-citationAT 1 Receptor Blockade and Atherosclerosis
Vaughan, D. E. (2000) · Circulation · doi:10.1161/01.cir.101.13.1496 · Cited by 33
Reconstitution of Angiotensin Receptor mRNA Down-regulation in Vascular Smooth Muscle
Xu, K., & Murphy, T. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7604 · Cited by 27
125l-Angiotensin II Binding to Human Blood Cells
Mann, J. F. E., Sis, J., & Ritz, E. (1985) · Journal of Hypertension · doi:10.1097/00004872-198504000-00004 · Cited by 21
Cited by
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
miR-155 gene: A typical multifunctional microRNA
Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 815
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 624
Datta, J., Kutay, H., Nasser, M. W., Nuovo, G. J., Wang, B., Majumder, S., Liu, C.-G., Volinia, S., Croce, C. M., Schmittgen, T. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6655 · Cited by 438
Self-citationRetractedMicroRNAs As Novel Regulators of Angiogenesis
Suárez, Y., & Sessa, W. C. (2009) · Circulation Research · doi:10.1161/circresaha.108.191270 · Cited by 416
Metadata
- Authors
- Martin, M. M., Buckenberger, J. A., Jiang, J., Malana, G. E., Nuovo, G. J., Chotani, M., Feldman, D. S., Schmittgen, T. D., & Elton, T. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 282
- Issue
- 33
- Pages
- 24262-24269
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035195993
- Cited by
- 259
- References
- 47
- FWCI
- 20.95
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.